MDA5 protein mediating persistent ER stress/unfolded protein response contributes to endothelial-mesenchymal-transition of lung microvascular endothelial cell in dermatomyositis
Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was stil...
Saved in:
Published in | Cell communication and signaling Vol. 23; no. 1; pp. 149 - 17 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
23.03.2025
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1478-811X 1478-811X |
DOI | 10.1186/s12964-025-02159-2 |
Cover
Abstract | Background
Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood.
Methods
Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used.
Results
Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients.
Conclusion
MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD. |
---|---|
AbstractList | Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood.BACKGROUNDDermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood.Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used.METHODSClinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used.Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients.RESULTSFirstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients.MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD.CONCLUSIONMDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD. Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Methods Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Results Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients. Conclusion MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD. Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-[beta] was found to induce MDA5 expression in DM patients. MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD. Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients. MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD. Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Methods Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Results Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-[beta] was found to induce MDA5 expression in DM patients. Conclusion MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD. Keywords: MDA5, Anti-MDA5 antibody, Dermatomyositis (DM), Interstitial lung disease (ILD), Endothelial-Mesenchymal-Transition (EndMT), Endoplasmic reticulum stress (ER stress), Unfolded protein responses (UPR) Abstract Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood. Methods Clinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used. Results Firstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients. Conclusion MDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD. BackgroundDermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of anti-MDA5 antibody positive DM has been already reported. However, the detailed role and mechanism of MDA5 in vascular damage was still poorly understood.MethodsClinical information was retrospectively collected, and a total of 127 DM patients were enrolled. Serum from DM patients and control subjects was used to treat mouse lung microvascular endothelial cells (MVECs) to investigate vascular changes. Western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, immunoprecipitation, protein mass spectrometry, flow cytometry and bioinformatics analysis were used.ResultsFirstly, clinical data analysis revealed that vascular damage and interstitial lung disease (ILD) was correlated with anti-MDA5 antibody in DM patients. Then, serum from patients was used to treat mouse lung MVECs. Serum from MDA5 + DM patients induced endothelial-mesenchymal-transition (EndMT) in MVECs, and the EndMT in MVECs was mediated by TRB3/ERK/Snai-1 pathway. Next, increased-TRB3 was confirmed induced by persistent ER stress/unfolded protein response (UPR). Notably, persistent ER stress/UPR resulted from MDA5 protein binding with PERK. At last, T cell-derived IFN-β was found to induce MDA5 expression in DM patients.ConclusionMDA5 protein mediating persistent ER stress/UPR contributed to EndMT in vascular endothelial cells, which should be involved in MDA5 + DM related ILD. |
ArticleNumber | 149 |
Audience | Academic |
Author | Ma, Wan-Li Feng, Xiao Zhang, He-De Zhao, Li-Qin Ye, Hong Ye, Shu-Yi Yang, Xue-Qing Jiang, Li-Juan Yu, Fan Niu, Qian |
Author_xml | – sequence: 1 givenname: Li-Qin surname: Zhao fullname: Zhao, Li-Qin organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 2 givenname: Xue-Qing surname: Yang fullname: Yang, Xue-Qing organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 3 givenname: Qian surname: Niu fullname: Niu, Qian organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 4 givenname: Xiao surname: Feng fullname: Feng, Xiao organization: Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology – sequence: 5 givenname: He-De surname: Zhang fullname: Zhang, He-De organization: Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology – sequence: 6 givenname: Shu-Yi surname: Ye fullname: Ye, Shu-Yi organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 7 givenname: Li-Juan surname: Jiang fullname: Jiang, Li-Juan organization: Department of Rheumatology and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 8 givenname: Fan surname: Yu fullname: Yu, Fan organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Respiratory Diseases, National Health Commission of China – sequence: 9 givenname: Hong surname: Ye fullname: Ye, Hong email: yehmwl@hust.edu.cn organization: Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Respiratory Diseases, National Health Commission of China, Basic School of Medicine, Tongji Medical College, Huazhong University of Science and Technology – sequence: 10 givenname: Wan-Li surname: Ma fullname: Ma, Wan-Li email: whmawl@hust.edu.cn organization: Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Respiratory Diseases, National Health Commission of China, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40122798$$D View this record in MEDLINE/PubMed |
BookMark | eNp9k9tu1DAQhiNURA_wAlygSNzARVqfkjhXaFUKVCpCKiBxZznOJPUqsbe2U7GPxRsy2y1tFyEURbEm3_-PPZ45zPacd5BlLyk5plRWJ5GyphIFYSW-tGwK9iQ7oKKWhaT0x96j9X52GOOSECZKUT_L9gWhjNWNPMh-fX6_KPNV8AmsyyforE7WDfkKQrQxgUv52WUeU4AYT2bX-7GD7p7H6Mq7CLnxLgXbzglinnwOrvPpCkarx2KCCM5crSdcp6BdtMl6l_s-H2dMNFkT_I2OZh51eCzMDYxjjkk6CJNOflr7jTQ-z572eozw4u57lH3_cPbt9FNx8eXj-eniojAl46kwkrTQakJEYwzvdMkpo0SwXrS00xyoMZK3VHdQk0a2RtaVaXVbNYxUErTmR9n51rfzeqlWwU46rJXXVt0GfBiUDsmaERTomghBeFlqKlpRog3vGO2BdVLXkqLXu63Xam6xxgbLGvS4Y7r7x9krNfgbRWnDCaEcHd7cOQR_PUNMarJxUyHtwM9RcSpx303JCKKv_0KXfg4Oa6U4I7SsKinqB2rQeAKLN4uJzcZULSRnjNd1XSF1_A8Knw7w4rAde4vxHcHbHcGmMeBnGvQcozr_ernLvnpclfty_OlOBNgWwBaJMUB_j1CiNiOgtiOgcATU7QgohiK-FUWE3QDh4fj_Uf0GSDAMqA |
Cites_doi | 10.1016/j.jaad.2010.09.016 10.1038/nature04734 10.1073/pnas.2313070121 10.1136/annrheumdis-2017-212149 10.1093/rheumatology/keu289 10.1111/1346-8138.13397 10.1016/j.jaad.2020.12.032 10.1016/j.celrep.2020.108628 10.1093/rheumatology/kead117 10.1016/j.chest.2020.04.057 10.3389/fimmu.2021.773352 10.1038/s41467-020-17798-x 10.1007/s10067-015-2935-9 10.1002/art.10924 10.1016/j.cell.2012.11.048 10.3390/genes10110864 10.1111/ced.14870 10.1146/annurev-pathol-012513-104649 10.1128/MCB.01009-12 10.1001/jamaneurol.2018.2598 10.1186/s12931-021-01908-4 10.1080/03079457.2018.1556386 10.1016/j.jaad.2010.08.004 10.3390/ijms23158193 10.1128/jvi.01388-22 10.1111/cup.14203 10.1136/ard.2010.139949 10.1002/jcp.28993 10.1146/annurev-biochem-062209-093836 10.1038/ni907 10.1016/j.semarthrit.2020.11.009 10.1126/science.aac7049 10.1038/nrm3270 10.1111/febs.14608 10.1093/rheumatology/kez357 10.1038/celldisc.2016.24 10.1016/j.jaad.2019.05.105 10.1152/ajpendo.00117.2006 10.1002/advs.202401327 10.1016/j.cell.2017.12.016 10.1016/j.tim.2018.08.007 10.1136/annrheumdis-2013-203279 10.1093/rheumatology/keac525 10.1002/art.40320 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7QP 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI RC3 7X8 5PM DOA |
DOI | 10.1186/s12964-025-02159-2 |
DatabaseName | Springer Nature OA Free Journals (ODIN) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1478-811X |
EndPage | 17 |
ExternalDocumentID | oai_doaj_org_article_ea70440355a14b45ab63d21fe2d8a781 PMC11930013 A832237776 40122798 10_1186_s12964_025_02159_2 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: the National Natural Science Foundation of China grantid: No. 82070066 and 82270075; No. 82270111 and 81973991 – fundername: the National Natural Science Foundation of China grantid: No. 82270111 and 81973991 – fundername: the National Natural Science Foundation of China grantid: No. 82070066 and 82270075 |
GroupedDBID | --- 0R~ 29B 2WC 53G 5VS 6J9 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IGS IHR INH INR ISR ITC KQ8 LK8 M1P M7P M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ XSB ~8M AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7QP 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. M48 P64 PKEHL PQEST PQUKI RC3 7X8 5PM |
ID | FETCH-LOGICAL-c523t-c80beba0049cc3da53121042f4b1da3e1cc83b1ade7098bc876cbab692068eaa3 |
IEDL.DBID | C6C |
ISSN | 1478-811X |
IngestDate | Wed Aug 27 01:32:51 EDT 2025 Thu Aug 21 18:40:07 EDT 2025 Fri Sep 05 05:41:44 EDT 2025 Fri Jul 25 19:29:34 EDT 2025 Tue Jun 17 21:59:04 EDT 2025 Tue Jun 10 20:59:53 EDT 2025 Fri Jun 27 05:12:55 EDT 2025 Mon Jul 21 06:02:08 EDT 2025 Tue Aug 05 12:12:14 EDT 2025 Sat Sep 06 07:22:37 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Interstitial lung disease (ILD) Anti-MDA5 antibody Unfolded protein responses (UPR) Endoplasmic reticulum stress (ER stress) Dermatomyositis (DM) Endothelial-Mesenchymal-Transition (EndMT) MDA5 |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c523t-c80beba0049cc3da53121042f4b1da3e1cc83b1ade7098bc876cbab692068eaa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doi.org/10.1186/s12964-025-02159-2 |
PMID | 40122798 |
PQID | 3201566847 |
PQPubID | 40257 |
PageCount | 17 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ea70440355a14b45ab63d21fe2d8a781 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11930013 proquest_miscellaneous_3180689520 proquest_journals_3201566847 gale_infotracmisc_A832237776 gale_infotracacademiconefile_A832237776 gale_incontextgauss_ISR_A832237776 pubmed_primary_40122798 crossref_primary_10_1186_s12964_025_02159_2 springer_journals_10_1186_s12964_025_02159_2 |
PublicationCentury | 2000 |
PublicationDate | 2025-03-23 |
PublicationDateYYYYMMDD | 2025-03-23 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Cell communication and signaling |
PublicationTitleAbbrev | Cell Commun Signal |
PublicationTitleAlternate | Cell Commun Signal |
PublicationYear | 2025 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | S Ahmad (2159_CR9) 2018; 172 T Schwartz (2159_CR49) 2014; 73 H Shakshouk (2159_CR8) 2022; 47 B Wu (2159_CR35) 2013; 152 A Lion (2159_CR13) 2019; 48 Y Kochi (2159_CR40) 2018; 77 A Meyer (2159_CR2) 2015; 54 KY Sun (2159_CR3) 2021; 51 IE Lundberg (2159_CR47) 2017; 69 RL Smith (2159_CR21) 2004; 31 X Yin (2159_CR12) 2021; 34 SA Oakes (2159_CR17) 2015; 10 CE Zhang (2159_CR41) 2016; 43 X Sun (2159_CR42) 2016; 2 R Waldman (2159_CR44) 2020; 82 D Fiorentino (2159_CR7) 2011; 65 X Lian (2159_CR46) 2023; 62 AP Liao (2159_CR37) 2011; 70 W Yu (2159_CR32) 2020; 21 A Almanza (2159_CR24) 2019; 286 A Nombel (2159_CR14) 2021; 12 RK Bode (2159_CR20) 2003; 49 X Cao (2159_CR22) 2021; 22 2159_CR4 X Lian (2159_CR5) 2020; 158 CD Scharer (2159_CR28) 2020; 11 Y Ichimura (2159_CR16) 2024; 121 W Cheng (2159_CR31) 2019; 19 SZ Yacoub Wasef (2159_CR30) 2006; 291 WK Yu (2159_CR29) 2022; 23 M Xue (2159_CR43) 2022; 96 X Chen (2159_CR45) 2024; 42 Y Abe (2159_CR25) 2020; 59 D Zheng (2159_CR33) 2024; 11 Y Liu (2159_CR36) 2023; 62 X Cao (2159_CR23) 2020; 235 K Mariampillai (2159_CR1) 2018; 75 NN Iwakoshi (2159_CR26) 2003; 4 S Zahn (2159_CR15) 2011; 64 L Li (2159_CR38) 2017; 2017 I Braakman (2159_CR18) 2011; 80 H Shakshouk (2159_CR6) 2022; 49 BJ Liddicoat (2159_CR10) 2015; 349 H Kato (2159_CR34) 2006; 441 Y Gao (2159_CR27) 2012; 32 A Wang (2159_CR48) 2021; 84 AG Dias Junior (2159_CR11) 2019; 27 C Hetz (2159_CR19) 2012; 13 J Song (2159_CR39) 2019; 10 |
References_xml | – volume: 65 start-page: 25 issue: 1 year: 2011 ident: 2159_CR7 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2010.09.016 – volume: 441 start-page: 101 issue: 7089 year: 2006 ident: 2159_CR34 publication-title: Nature doi: 10.1038/nature04734 – volume: 121 start-page: e2313070121 issue: 16 year: 2024 ident: 2159_CR16 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.2313070121 – volume: 77 start-page: 602 issue: 4 year: 2018 ident: 2159_CR40 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2017-212149 – volume: 31 start-page: 1644 issue: 8 year: 2004 ident: 2159_CR21 publication-title: J Rheumatol – volume: 54 start-page: 50 issue: 1 year: 2015 ident: 2159_CR2 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keu289 – volume: 43 start-page: 1307 issue: 11 year: 2016 ident: 2159_CR41 publication-title: J Dermatol doi: 10.1111/1346-8138.13397 – volume: 19 start-page: 2869 issue: 4 year: 2019 ident: 2159_CR31 publication-title: Mol Med Rep – volume: 84 start-page: 1610 issue: 6 year: 2021 ident: 2159_CR48 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2020.12.032 – volume: 34 start-page: 108628 issue: 2 year: 2021 ident: 2159_CR12 publication-title: Cell Rep doi: 10.1016/j.celrep.2020.108628 – volume: 62 start-page: 3724 issue: 11 year: 2023 ident: 2159_CR36 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kead117 – volume: 158 start-page: 1535 issue: 4 year: 2020 ident: 2159_CR5 publication-title: Chest doi: 10.1016/j.chest.2020.04.057 – volume: 21 start-page: 615 issue: 2 year: 2020 ident: 2159_CR32 publication-title: Mol Med Rep – volume: 12 start-page: 773352 year: 2021 ident: 2159_CR14 publication-title: Front Immunol doi: 10.3389/fimmu.2021.773352 – volume: 11 start-page: 3989 issue: 1 year: 2020 ident: 2159_CR28 publication-title: Nat Commun doi: 10.1038/s41467-020-17798-x – ident: 2159_CR4 doi: 10.1007/s10067-015-2935-9 – volume: 49 start-page: 7 issue: 1 year: 2003 ident: 2159_CR20 publication-title: Arthritis Rheum doi: 10.1002/art.10924 – volume: 152 start-page: 276 issue: 1–2 year: 2013 ident: 2159_CR35 publication-title: Cell doi: 10.1016/j.cell.2012.11.048 – volume: 10 start-page: 864 issue: 11 year: 2019 ident: 2159_CR39 publication-title: Genes (Basel) doi: 10.3390/genes10110864 – volume: 47 start-page: 282 issue: 2 year: 2022 ident: 2159_CR8 publication-title: Clin Exp Dermatol doi: 10.1111/ced.14870 – volume: 10 start-page: 173 year: 2015 ident: 2159_CR17 publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-012513-104649 – volume: 32 start-page: 5129 issue: 24 year: 2012 ident: 2159_CR27 publication-title: Mol Cell Biol doi: 10.1128/MCB.01009-12 – volume: 75 start-page: 1528 issue: 12 year: 2018 ident: 2159_CR1 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2018.2598 – volume: 22 start-page: 312 issue: 1 year: 2021 ident: 2159_CR22 publication-title: Respir Res doi: 10.1186/s12931-021-01908-4 – volume: 48 start-page: 121 issue: 2 year: 2019 ident: 2159_CR13 publication-title: Avian Pathol doi: 10.1080/03079457.2018.1556386 – volume: 64 start-page: 988 issue: 5 year: 2011 ident: 2159_CR15 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2010.08.004 – volume: 23 start-page: 8193 issue: 15 year: 2022 ident: 2159_CR29 publication-title: Int J Mol Sci doi: 10.3390/ijms23158193 – volume: 42 start-page: 386 issue: 2 year: 2024 ident: 2159_CR45 publication-title: Clin Exp Rheumatol – volume: 96 start-page: e0138822 issue: 24 year: 2022 ident: 2159_CR43 publication-title: J Virol doi: 10.1128/jvi.01388-22 – volume: 49 start-page: 442 issue: 5 year: 2022 ident: 2159_CR6 publication-title: J Cutan Pathol doi: 10.1111/cup.14203 – volume: 70 start-page: 831 issue: 5 year: 2011 ident: 2159_CR37 publication-title: Ann Rheum Dis doi: 10.1136/ard.2010.139949 – volume: 235 start-page: 538 issue: 1 year: 2020 ident: 2159_CR23 publication-title: J Cell Physiol doi: 10.1002/jcp.28993 – volume: 80 start-page: 71 issue: 1 year: 2011 ident: 2159_CR18 publication-title: Annu Rev Biochem doi: 10.1146/annurev-biochem-062209-093836 – volume: 4 start-page: 321 issue: 4 year: 2003 ident: 2159_CR26 publication-title: Nat Immunol doi: 10.1038/ni907 – volume: 51 start-page: 175 issue: 1 year: 2021 ident: 2159_CR3 publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2020.11.009 – volume: 349 start-page: 1115 issue: 6252 year: 2015 ident: 2159_CR10 publication-title: Science doi: 10.1126/science.aac7049 – volume: 13 start-page: 89 issue: 2 year: 2012 ident: 2159_CR19 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm3270 – volume: 286 start-page: 241 issue: 2 year: 2019 ident: 2159_CR24 publication-title: FEBS J doi: 10.1111/febs.14608 – volume: 59 start-page: 767 issue: 4 year: 2020 ident: 2159_CR25 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kez357 – volume: 2 start-page: 16024 year: 2016 ident: 2159_CR42 publication-title: Cell Discov doi: 10.1038/celldisc.2016.24 – volume: 82 start-page: 283 issue: 2 year: 2020 ident: 2159_CR44 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2019.05.105 – volume: 291 start-page: E1274 issue: 6 year: 2006 ident: 2159_CR30 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00117.2006 – volume: 11 start-page: e2401327 issue: 28 year: 2024 ident: 2159_CR33 publication-title: Adv Sci (Weinh) doi: 10.1002/advs.202401327 – volume: 172 start-page: 797 issue: 4 year: 2018 ident: 2159_CR9 publication-title: Cell doi: 10.1016/j.cell.2017.12.016 – volume: 27 start-page: 75 issue: 1 year: 2019 ident: 2159_CR11 publication-title: Trends Microbiol doi: 10.1016/j.tim.2018.08.007 – volume: 73 start-page: 1805 issue: 10 year: 2014 ident: 2159_CR49 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-203279 – volume: 62 start-page: 1910 issue: 5 year: 2023 ident: 2159_CR46 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keac525 – volume: 69 start-page: 2271 issue: 12 year: 2017 ident: 2159_CR47 publication-title: Arthritis Rheumatol doi: 10.1002/art.40320 – volume: 2017 start-page: 2905987 year: 2017 ident: 2159_CR38 publication-title: Biomed Res Int |
SSID | ssj0024547 |
Score | 2.374247 |
Snippet | Background
Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The... Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of... Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The model of... Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The... BackgroundDermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the disease. The... Abstract Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy. Anti-MDA5 antibody positive DM (MDA5 + DM) is a distinct subtype of the... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 149 |
SubjectTerms | Adult Animals Anti-MDA5 antibody Antibodies Apoptosis B cells Bioinformatics Biomedical and Life Sciences Biopsy Blood circulation disorders Cell Biology Cell differentiation Complications and side effects Cytokines and Growth Factors Dermatomyositis Dermatomyositis (DM) Dermatomyositis - metabolism Dermatomyositis - pathology Development and progression Disease Endoplasmic reticulum Endoplasmic Reticulum Stress Endoplasmic reticulum stress (ER stress) Endothelial cells Endothelial Cells - metabolism Endothelial Cells - pathology Endothelial-Mesenchymal-Transition (EndMT) Endothelium Enzymes Epithelial cells Epithelial-Mesenchymal Transition Female Flow cytometry Health aspects Homeostasis Humans Immunofluorescence Immunoprecipitation Interferon-Induced Helicase, IFIH1 - metabolism Interstitial lung disease (ILD) Kinases Life Sciences Lung - blood supply Lung - pathology Lung diseases Lung diseases, Interstitial Lymphocytes T Male Mass spectrometry Mass spectroscopy MDA5 Medical research Mice Microvasculature Microvessels - pathology Middle Aged Myopathy Patients Pattern recognition receptors Phosphorylation Polymerase chain reaction Protein binding Protein folding Protein-Ligand Interactions Proteins Receptors Risk factors Skin Stem cells T cells Transcription factors Vascular endothelium Viral antibodies Western blotting β-Interferon |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQJSQuiG8CBRmExAGsJnYcO8cFWhWkcihU6s1ybIdW2k2qJnvYn8U_ZMZJlk0R4sItWk-UZObZ41m_mSHkjfBp6bmzDACiWS7qipWlEqyWzme5dYAiTBQ--Vocn-VfzuX5Tqsv5IQN5YEHxR0Eq7ArMrhFm-VVLm1VCM-zOnCvrYpJ1zwt0ymYmqrsyVxNKTK6OOgyPF1k2LoVfVzJ-MwNxWr9f67JO07pJmHyxqlpdEZH98jdcRdJF8Pb3ye3QvOA3B76Sm4ekp8nnxaSxhIMlw2NySHIbqZX-OcYmLXp6eEpHdJEDtYAsaUPfit_PdBmA400duyHFTratzQ0HtO1loBYtsKkJXexWcF1j-4uMr9oW9MlrB50hTS_ieS6eyPFgwIKD_HoEfp2tYmkse4ROTs6_P7xmI29GZiD0LVnTqdVqCwGGM4Jb2EqQ_CY8zqvMm9FyJzTosqsDyotdeVg0XUV2K7kaaGDteIx2WvaJjwlVMm8clJbLhxshqTWFos0OlkWTrnCy4S8m0xlroYSHCaGLrowg2ENGNZEwxqekA9oza0kls-OPwCozAgq8y9QJeQ1YsFggYwGGTg_7LrrzOdvp2aBS6BQShUJeTsK1S1o2tkxoQG-CmtqzST3Z5Iwg918eIKcGVeQzgiOSe4FbB4S8mo7jHciK64J7RpkMg3aLCVPE_JkQOj2u3M8M1WlToieYXemmPlIc3kR64tnsKnH0CAh7yeY_36vv2v-2f_Q_HNyh8dpKhgX-2Svv16HF7Dt66uXcYb_Ahi0V0E priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgCIkXxPcCAxmExANYa-wkdp5QgU0DaTwMJvXNcmxnm9QmpUkf-mfxH3LnJO0yBG9VfFFj35fP_t0dIW-Fm-SOW8NAQBRLRFmwPJeClal1cWIsSBEmCp9-z07Ok2-zdNYfuDU9rHKwicFQu9riGfmh4Jj0m4Ex_bj8xbBrFN6u9i00bpM7oXQZyLOc7QIuLFY1JMqo7LCJ8Y6RYQNX9HQ54yNnFGr2_22Zr7mmm7DJG3enwSUdPyD3-70knXbMf0hu-eoRudt1l9w8Jr9Pv0xTGgoxXFU0pIggxpku8YgMmFu19OiMdskih2sQtLnzbku_6sCzngYwO3bF8g1ta-orh0lbc5BbtsDUJXu5WcDvFp1ewH_RuqRzsCF0gWC_Aep6_UWK1wUU_sShX2jrxSZAx5on5Pz46OfnE9Z3aGAWAtiWWTUpfGEwzLBWOAMKDSFkwsukiJ0RPrZWiSI2zstJrgoLptcWpshyPsmUN0Y8JXtVXfl9QmWaFDZVhgsLW6JUKYOlGm2aZ1bazKUReT-wSi-7Qhw6BDAq0x1jNTBWB8ZqHpFPyM0tJRbRDg_q1YXudVJ7I7HhNuy4TJwUSQofJhyPS8-dMlLFEXmDsqCxTEaFOJwLs24a_fXHmZ6iIRRSyiwi73qisoaVtqZPa4BZYWWtEeXBiBL02I6HB5HTvR1p9E7qI_J6O4xvIjau8vUaaGIFq5mnfBKRZ52Ebued4M2pzFVE1Eh2RwszHqmuLkOVcVAogQFCRD4MYr77rn-v_PP_T-MFuceDAgrGxQHZa1dr_xK2dW3xKujuH0BDTy0 priority: 102 providerName: ProQuest |
Title | MDA5 protein mediating persistent ER stress/unfolded protein response contributes to endothelial-mesenchymal-transition of lung microvascular endothelial cell in dermatomyositis |
URI | https://link.springer.com/article/10.1186/s12964-025-02159-2 https://www.ncbi.nlm.nih.gov/pubmed/40122798 https://www.proquest.com/docview/3201566847 https://www.proquest.com/docview/3180689520 https://pubmed.ncbi.nlm.nih.gov/PMC11930013 https://doaj.org/article/ea70440355a14b45ab63d21fe2d8a781 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1Nb9Mw1IJNSFwQ3wRGZRASB4hWx3HsHNvRaSBtQoVJFRfLsR02qU2mNT30Z_EPec9Ju2bAgUsV1c9K4ved90XIO-6GuUusiYFAVJzysojzXPK4FNax1FigIiwUPj3LTs7TLzMx69rkYC3MbvyeqexwyTAuGOPQVdROeQzidl8wnoXAbHZ001dPpHJTFPPXfT3FE_rz_ymFd9TQ7RTJW3HSoH6OH5IHnd1IRy2iH5E7vnpM7rWTJNdPyK_TTyNBQ9OFy4qGchDMZ6ZX-DkMEFk1dDKlbWHI4QqIau6828Jft4mynobEdZyA5Ze0qamvHBZozYFG4wWWKdmL9QKuG1RwIdeL1iWdg7ygC0zs26S17m6kGBqgcBOHOqCpF-uQJrZ8Ss6PJ9-PTuJuGkNswVltYquGhS8MuhTWcmeAecFdTJMyLZgz3DNrFS-YcV4Oc1VYELO2MEWWJ8NMeWP4M7JX1ZV_QagUaWGFMgm3YP4IpQy2ZbQiz6y0mRMR-bBBlb5qm27o4KyoTLeI1YBYHRCrk4iMEZtbSGyYHf4AOtId_2lvJA7XBuvKsLRIBTwYdwkrfeKUkYpF5C3SgsaWGBXm3Pw0q-VSf_421SMUelxKmUXkfQdU1nDS1nQlDPBW2EWrB3nQgwSetf3lDcnpTmYsNU-wrD0DcyEib7bLuBPz4CpfrwCGKTjNXCTDiDxvKXT73ilGSWWuIqJ6tNs7mP5KdXkROoozMOPRGYjIxw2Z3zzXv0_-5f-BvyL3k8CQPE74Adlrrlf-NZh0TTEgd-VMDsj-eHL2dToInD0In0fgdzr-8Ru9sUyS |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGJgQviG8CAwwC8QDRGjsfzgNCHeu0sbVCZZP2Zhzb3SatyWhSof5TSPyH3DlJtwzB296q5tLGvp_vfPHv7gh5w00vNUwrHwAi_JBPMj9NE-5PIm2CUGlAESYKD0fxzmH45Sg6WiG_2lwYpFW2NtEZalNofEe-wRkm_cZgTD-d__CxaxSerrYtNGpY7NnFTwjZyo-7W6Dft4xtDw4-7_hNVwFfQ9BV-Vr0Mpsp3BprzY0CEELYE7JJmAVGcRtoLXgWKGOTXioyDeZCZyqLU9aLhVWKw-_eIGshZrSukrXNwejr-KK6XxQmbWqOiDfKAE81fWwZi7419VnH_bkuAX_7gkvO8CpR88pprXOC23fJnWb3Svs13O6RFZvfJzfrfpaLB-T3cKsfUVf64TSnLikFWdX0HF_KAZzyig7GtE5P2ZgDtM-MNUv5WU3XtdTR57EPly1pVVCbG0wTO4OV4k8xWUqfLKbwuUI36xhntJjQM7BadIr0wpZce_lGigcUFP7EoCeqiunCkdXKh-TwWrT3iKzmRW6fEJpEYaYjoRjXsAmLhFBYHFJHaawTHZvII-9bVcnzuvSHdCGTiGWtWAmKlU6xknlkE7W5lMSy3e6LYnYsGysgrUqwxTfs8VQQZmEED8YNCyaWGaESEXjkNWJBYmGOHJk_x2pelnL321j20fTyJElij7xrhCYFzLRWTSIFjApreXUk1zuSYDl093ILOdlYrlJerDOPvFpexjuRjZfbYg4ygYDZTCPW88jjGqHLcYd4VpukwiOig93OxHSv5Kcnrq55AMEEhiQe-dDC_OK5_j3zT_8_jJfk1s7BcF_u7472npHbzC1G7jO-Tlar2dw-h01llb1oVjIl36_bePwBuCuOyg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFLfQEIgL4pvAAIOQOEDUJnZi51i2VRuwCQ0m7WY5trNNapOqSQ_9s_gPec9JumbAgVtUPyux36f7fu-ZkPfMjjMbGx2CgMiQsyIPs0ywsEiMjbg2IEVYKHx8kh6e8S_nyflWFb9Hu_cpybamAbs0lc1oYYtWxWU6qiPMFoZ4FSv6rCwEI3ybo-vDdG26d91tL-GiL5X567yBO_Jd-_-0zVvO6SZw8kb21Dul6QNyv4sm6aRl_0Nyy5WPyJ32fsn1Y_LreH-SUN-K4aqkvkgEUc50gX-S1bheenBK23KR0QpEbWad3dAvW_isox7OjvdiuZo2FXWlxbKtGUhuOMfiJXO5nsNzg27PI8BoVdAZWBE6R7hfD3bdnkgxYUDhJRY9Q1PN1x48Vj8hZ9ODn3uHYXdHQ2jgCNuERo5zl2s8aBjDrAaVhkMkjwueR1YzFxkjWR5p68Q4k7kB42tynadZPE6l05o9JTtlVbrnhIqE5yaROmYGgqJESo3NGk2SpUaY1CYB-dizSi3aVhzKH2FkqlrGKmCs8oxVcUA-Izc3lNhG2_9QLS9Up5XKaYFXbkPMpSOe8wQ-jNk4KlxspRYyCsg7lAWFjTJKROJc6FVdq6Mfp2qCppAJIdKAfOiIigp22uiusAFWhb21BpS7A0rQZDMc7kVOdZakVizGYvcUgoiAvN0M40xEx5WuWgFNJGE3syQeB-RZK6GbdXPMnYpMBkQOZHewMcOR8urS9xmPILjHI0JAPvVifv1d_975F_9H_obc_b4_Vd-OTr6-JPdir5ssjNku2WmWK_cKYr4mf-3V-jf0aFNB |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MDA5+protein+mediating+persistent+ER+stress%2Funfolded+protein+response+contributes+to+endothelial-mesenchymal-transition+of+lung+microvascular+endothelial+cell+in+dermatomyositis&rft.jtitle=Cell+communication+and+signaling&rft.au=Zhao%2C+Li-Qin&rft.au=Yang%2C+Xue-Qing&rft.au=Niu%2C+Qian&rft.au=Feng%2C+Xiao&rft.date=2025-03-23&rft.pub=BioMed+Central+Ltd&rft.issn=1478-811X&rft.eissn=1478-811X&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs12964-025-02159-2&rft.externalDocID=A832237776 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-811X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-811X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-811X&client=summon |